244 related articles for article (PubMed ID: 32366577)
1. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes.
Ilkun OL; Greene T; Cheung AK; Whelton PK; Wei G; Boucher RE; Ambrosius W; Chertow GM; Beddhu S
Diabetes Care; 2020 Aug; 43(8):1878-1884. PubMed ID: 32366577
[TBL] [Abstract][Full Text] [Related]
2. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
3. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
[TBL] [Abstract][Full Text] [Related]
4. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
[TBL] [Abstract][Full Text] [Related]
5. Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.
Foy AJ; Filippone EJ; Schaefer E; Nudy M; Ruzieh M; Dyer AM; Chinchilli VM; Naccarelli GV
JAMA Netw Open; 2021 Oct; 4(10):e2128980. PubMed ID: 34668944
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure targets for hypertension in people with diabetes mellitus.
Arguedas JA; Leiva V; Wright JM
Cochrane Database Syst Rev; 2013 Oct; (10):CD008277. PubMed ID: 24170669
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
Bergmark BA; Scirica BM; Steg PG; Fanola CL; Gurmu Y; Mosenzon O; Cahn A; Raz I; Bhatt DL;
Eur Heart J; 2018 Jun; 39(24):2255-2262. PubMed ID: 29394350
[TBL] [Abstract][Full Text] [Related]
8. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
Ruilope LM; Usan L; Segura J; Bakris GL
J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Marx N; Sliwa K; Weber MA; Williams B; Yusuf S
Eur Heart J; 2019 Jul; 40(25):2032-2043. PubMed ID: 30919899
[TBL] [Abstract][Full Text] [Related]
10. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
[TBL] [Abstract][Full Text] [Related]
11. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
Hata J; Arima H; Rothwell PM; Woodward M; Zoungas S; Anderson C; Patel A; Neal B; Glasziou P; Hamet P; Mancia G; Poulter N; Williams B; Macmahon S; Chalmers J;
Circulation; 2013 Sep; 128(12):1325-34. PubMed ID: 23926207
[TBL] [Abstract][Full Text] [Related]
12. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S
Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709
[TBL] [Abstract][Full Text] [Related]
13. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
14. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
[TBL] [Abstract][Full Text] [Related]
15. Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials.
Liu J; Pong A; Gallo S; Darekar A; Terra SG
Cardiovasc Diabetol; 2019 May; 18(1):59. PubMed ID: 31064361
[TBL] [Abstract][Full Text] [Related]
16. Effects of dapagliflozin on blood pressure in hypertensive diabetic patients on renin-angiotensin system blockade.
Weber MA; Mansfield TA; Alessi F; Iqbal N; Parikh S; Ptaszynska A
Blood Press; 2016; 25(2):93-103. PubMed ID: 26623980
[TBL] [Abstract][Full Text] [Related]
17. Influence of Baseline Diastolic Blood Pressure on the Effects of Systolic Blood Pressure Lowering on Cognitive Function in Type 2 Diabetes Mellitus.
Gupta A; Boucher R; Wei G; Gronseth G; Parks A; Beddhu S
Am J Hypertens; 2023 Feb; 36(2):120-125. PubMed ID: 36227718
[TBL] [Abstract][Full Text] [Related]
18. Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering: Results From the STEP Randomized Trial.
Yang R; Huang R; Zhang L; Li D; Luo J; Cai J
Hypertension; 2023 Dec; 80(12):2572-2580. PubMed ID: 37814892
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients.
Mancia G; Omboni S; Agabiti-Rosei E; Casati R; Fogari R; Leonetti G; Montemurro G; Nami R; Pessina AC; Pirrelli A; Zanchetti A
J Cardiovasc Pharmacol; 2000 Jun; 35(6):926-31. PubMed ID: 10836728
[TBL] [Abstract][Full Text] [Related]
20. Association of RASGRP1 polymorphism with vascular complications in Chinese diabetic patients with glycemic control and antihypertensive treatment.
Zhou J; Xu B; He F; Shu Y; Chen X; Liu Z; Sun B; Zhang W
Cardiovasc Diabetol; 2024 May; 23(1):166. PubMed ID: 38730425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
